CAS: 1346133-08-1
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | LY-2795050 REF: AN-AG009CCVCAS: 1346133-08-1 | 97% | A consultar | Vie 10 May 24 |
 | LY2795050 REF: TM-TQ0091CAS: 1346133-08-1 | 97.77% | 86,00 €~698,00 € | Vie 17 May 24 |
 | LY2795050 REF: 3D-WDC13308CAS: 1346133-08-1 | Min. 95% | A consultar | Vie 21 Jun 24 |
Ref: AN-AG009CCV
| 1mg | A consultar | |
| 2mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 10 de Mayo de 2024
LY2795050
CAS:1346133-08-1
LY2795050 is a novel specific κ-Opioid Receptor antagonist (IC50: 0.72 nM).
Fórmula:
C23H22ClN3O2
Pureza:
97.77%
Forma y color:
Solid
Peso molecular:
407.89
Ref: TM-TQ0091
| 1mg | 86,00 € | |
| 2mg | 113,00 € | |
| 5mg | 185,00 € | |
| 10mg | 296,00 € | |
| 25mg | 485,00 € | |
| 50mg | 698,00 € | |
| 1ml*10 (DMSO) | 201,00 € |
Entrega estimada en Estados Unidos, el Viernes 17 de Mayo de 2024
LY2795050
CAS:1346133-08-1
LY2795050 is a drug that acts as a δ receptor agonist. It has been shown …
Fórmula:
C23H22ClN3O2
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
407.89 g/mol
Ref: 3D-WDC13308
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 21 de Junio de 2024
